3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Observational
1
Sponsor
Cancer Type
Gastrointestinal
1
Conditions
Barrett Esophagus
15
Esophageal Neoplasms
10
Colorectal Neoplasms
10
Rectal Neoplasms
7
Adenocarcinoma Of Esophagus
7
Stomach Neoplasms
6
Colonic Neoplasms
5
Gastroesophageal Reflux
4
Colorectal Neoplasms, Hereditary Nonpolyposis
3
Precancerous Conditions
2
Pathologic Complete Response
2
Esophageal Squamous Cell Carcinoma
2
Carcinoma
2
Adenomatous Polyposis Coli
2
Adenocarcinoma
2
Stomach Ulcer
1
Stomach Diseases
1
Recurrence
1
Polyps
1
Polyposis, Gastric
1
Pancreatic Pseudocyst
1
Neoplasms
1
Metaplasia
1
Locally Advanced Pancreatic Cancer
1
Hyperplasia
1
Gastroparesis
1
Gastrointestinal Neoplasms
1
Gastrointestinal Diseases
1
Gastric Outlet Obstruction
1
Fistula
1
Interventions
Gemcitabine
6
130-nm albumin-bound paclitaxel
4
S 1 (combination)
2
Radiosurgery
2
Oxaliplatin
2
Leucovorin
2
Fluorouracil
2
Electroporation
2
zimberelimab
1
surufatinib
1
Tomography, X-Ray Computed
1
Pancreatectomy
1
Irinotecan
1
Immunotherapy
1
Heavy Ion Radiotherapy
1
Endoscopy
1
Drug Therapy
1
Diagnostic Imaging
1
Albumin-Bound Paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Locally Advanced Pancreatic Cancer
×
Endoscopy
×
Gastrointestinal
×
Clear all
NCT06944587
2025-04-25
NORPACT-3
Oslo University Hospital
Recruiting
400 enrolled